Program

""

Program Schedule


 

3:30 p.m.

Check in Begins

4:00 p.m.

Welcome Address

4:10 p.m.

Generating Health: Moving Up the Value Curve for LLMs
Ratnendra “Saibu” Sharma, MS - Senior Director, Managed Analytics & Health Equity Analytics Practice Lead, Optum

Deploying AI and machine learning in population health presents both extraordinary potential and complex oversight challenges. Drawing on work from Optum’s Managed Analytics and Health Equity Analytics teams, this talk will focus on the “in-between” space—where models move from concept to real-world application. Strategies for monitoring bias, validating performance, and maintaining safety in dynamic, data-rich environments. The session will highlight opportunities for collaboration across technical and clinical teams to ensure LLMs generate not just insights, but measurable, equitable value.

4:35 p.m.

Why Business Model Innovation Deserves the Healthcare Spotlight
Matt Scholl, MBA - Founder and Partner, TrueNorth Health Ventures

While technology drives what’s possible in healthcare, business model innovation determines how those possibilities reach people. History shows that disruptive delivery models—not just new inventions—create lasting impact. In healthcare, rethinking how we deliver and pay for care is key to solving challenges of cost and access. The future belongs to leaders who blend technological insight with innovative business models.

5:00 p.m.

Break

5:10 p.m.

Navigating Change and Unlocking Value In Medtech’s New Era
Laura Philippsen, MBA - Vice President, Corporate Strategy, Solventum

In a time of rapid disruption, how are Medtech leaders redefining value? This session takes an inside look at how strategic M&A and portfolio management are driving innovation, accelerating growth, and shaping the future of healthcare. With insights drawn from the Solventum spin-off, it uncovers bold strategies that turn complex change into patient-centered progress and long-term impact.

5:35 p.m.

2025 MedTech Trends & Implications
Sahil Sanghvi, MBA - Managing Director and Partner, Boston Consulting Group

Drawing from BCG’s global perspective, this session explores how M&A and strategic partnerships are redefining innovation pathways, the rise of agentic AI and its real-world impact on clinical and commercial decision-making, and the mounting pricing and access pressures challenging traditional business models. Attendees will gain actionable insights for navigating the intersection of technology, regulation, and market dynamics in an increasingly value-driven healthcare landscape.

6:00 p.m.

Closing Remarks

6:00 - 7:00 p.m.

Networking Reception